149 related articles for article (PubMed ID: 37337500)
1. Efficacy of Rituximab in CANOMAD: A Systematic Review.
Aguirre AS; Vivanco RA; Ortiz JF; Rozen V; InsuastI WE; Fiallos J; Gallegos C; Villavicencio A; Salazar K; Duenas F; Singla R
Cureus; 2023 May; 15(5):e39237. PubMed ID: 37337500
[TBL] [Abstract][Full Text] [Related]
2. CANOMAD: a neurological monoclonal gammopathy of clinical significance that benefits from B-cell-targeted therapies.
Le Cann M; Bouhour F; Viala K; Simon L; Tard C; Rossi C; Morel G; Lagrange E; Magy L; Créange A; Michaud M; Franques J; Echaniz-Laguna A; Antoine JC; Baron M; Arnulf B; Puma A; Delmont E; Maisonobe T; Leblond V; Roos-Weil D
Blood; 2020 Nov; 136(21):2428-2436. PubMed ID: 32959046
[TBL] [Abstract][Full Text] [Related]
3. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
4. CANOMAD and other chronic ataxic neuropathies with disialosyl antibodies (CANDA).
Garcia-Santibanez R; Zaidman CM; Sommerville RB; Lopate G; Weihl CC; Pestronk A; Bucelli RC
J Neurol; 2018 Jun; 265(6):1402-1409. PubMed ID: 29633012
[TBL] [Abstract][Full Text] [Related]
5. The clinical and laboratory features of chronic sensory ataxic neuropathy with anti-disialosyl IgM antibodies.
Willison HJ; O'Leary CP; Veitch J; Blumhardt LD; Busby M; Donaghy M; Fuhr P; Ford H; Hahn A; Renaud S; Katifi HA; Ponsford S; Reuber M; Steck A; Sutton I; Schady W; Thomas PK; Thompson AJ; Vallat JM; Winer J
Brain; 2001 Oct; 124(Pt 10):1968-77. PubMed ID: 11571215
[TBL] [Abstract][Full Text] [Related]
6. Excellent response to anti-CD38 therapy with daratumumab in a patient with severe refractory CANOMAD.
Pascual-Goñi E; Collet R; Tejada-Illa C; Martín-Aguilar L; Caballero-Ávila M; Lleixà C; Novelli S; López-Pardo J; Sanfeliu AE; Mariscal A; Álvaro Gargallo Y; Martínez-Hernández E; Cocho D; Querol L
J Neurol Neurosurg Psychiatry; 2024 Feb; ():. PubMed ID: 38341197
[TBL] [Abstract][Full Text] [Related]
7. CANOMAD syndrome with respiratory failure.
Salamon A; Dézsi L; Radics B; Varga ET; Hortobágyi T; Tömösvári A; Vécsei L; Klivényi P; Rajda C
Ideggyogy Sz; 2020 Mar; 73(3-4):141-144. PubMed ID: 32364342
[TBL] [Abstract][Full Text] [Related]
8. [Identification and characterization of a monoclonal IgM reacting with disialylated gangliosides recognizing the CANOMAD syndrome].
Boussaïd I; Bouhour F; Vial C; Caudie C
Ann Biol Clin (Paris); 2011; 69(4):476-80. PubMed ID: 21896416
[TBL] [Abstract][Full Text] [Related]
9. Canomad presenting without ophthalmoplegia and responding to intravenous immunoglobulin.
Kam C; Balaratnam MS; Purves A; Mills KR; Riordan-Eva P; Pollock S; Bodi I; Munro NA; Bennett DL
Muscle Nerve; 2011 Nov; 44(5):829-33. PubMed ID: 22006700
[TBL] [Abstract][Full Text] [Related]
10. Immunotherapy for IgM anti-myelin-associated glycoprotein paraprotein-associated peripheral neuropathies.
Lunn MP; Nobile-Orazio E
Cochrane Database Syst Rev; 2016 Oct; 10(10):CD002827. PubMed ID: 27701752
[TBL] [Abstract][Full Text] [Related]
11. The future of Cochrane Neonatal.
Soll RF; Ovelman C; McGuire W
Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
[TBL] [Abstract][Full Text] [Related]
12. Chronic ataxic neuropathy mimicking dorsal midbrain syndrome.
Arbogast SD; Khanna S; Koontz DW; Tomsak RL; Katirji B; Leigh RJ
J Neurol Neurosurg Psychiatry; 2007 Nov; 78(11):1276-7. PubMed ID: 17504882
[TBL] [Abstract][Full Text] [Related]
13. [Polyneuropathy associated with monoclonal gammapathy: treatment perspectives].
Leger JM; Chassande B; Bombelli F; Viala K; Musset L; Neil J
Bull Acad Natl Med; 2009 May; 193(5):1099-110; discussion 1110-1. PubMed ID: 20120390
[TBL] [Abstract][Full Text] [Related]
14. Canomad: report of a case with a 40-year history and autopsy. Is this a sensory ganglionopathy with neuromuscular junction blockade?
McKelvie PA; Gates PC; Day T
Muscle Nerve; 2013 Oct; 48(4):599-603. PubMed ID: 23649749
[TBL] [Abstract][Full Text] [Related]
15. [A syndrome of chronic ataxic polyneuropathy, ophtalmoplegia, IgM paraprotein, cold agglutinins and anti-disialosyl antibodies can cause diplopia in patients with chronic sensory polyneuropathy].
Kolmos EB; Moth Henriksen M; Abildgaard N; Sindrup SH
Ugeskr Laeger; 2012 Oct; 174(43):2635-6. PubMed ID: 23095653
[TBL] [Abstract][Full Text] [Related]
16. Successful treatment with rituximab of one patient with CANOMAD neuropathy.
Delmont E; Jeandel PY; Hubert AM; Marcq L; Boucraut J; Desnuelle C
J Neurol; 2010 Apr; 257(4):655-7. PubMed ID: 19960199
[TBL] [Abstract][Full Text] [Related]
17. Lack of association between dental implants and oral squamous cell carcinoma.
Afrashtehfar KI; Almomani MM; Momani M
Evid Based Dent; 2022 Mar; 23(1):40-42. PubMed ID: 35338331
[TBL] [Abstract][Full Text] [Related]
18. CANOMAD responding to weekly treatment with intravenous immunoglobulin (IVIg).
Krenn M; Keir G; Wieshmann UC
BMJ Case Rep; 2014 Apr; 2014():. PubMed ID: 24722712
[TBL] [Abstract][Full Text] [Related]
19. Immunotherapy for IgM anti-myelin-associated glycoprotein paraprotein-associated peripheral neuropathies.
Lunn MP; Nobile-Orazio E
Cochrane Database Syst Rev; 2012 May; (5):CD002827. PubMed ID: 22592686
[TBL] [Abstract][Full Text] [Related]
20. Clinical Efficacy of Bendamustine Plus Rituximab (BR) for B-cell Relevant Indolent Non-Hodgkin's Lymphoma and Role of
Zhang Y; He D; He J; Huang W; Yang Y; Cai Z; Zhao Y
Comput Math Methods Med; 2022; 2022():1080879. PubMed ID: 35096126
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
